December 13, 2024 · Form 4 insider transaction
Wilson Mark Andrew bought 325,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Stock options vest over four years from the date of grant, (December 13, 2024) in equal monthly installments based on continued service.